Key facts
- This page summarizes John G. Stratton's Form 4 filing for ABBOTT LABORATORIES (ABT).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 28 Apr 2026, 19:45.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Additional SEC filing notes
Footnote F1
Restricted stock unit award granted under the Abbott Laboratories 2026 Incentive Stock Program (the "Program"). The award will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).